{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:54:56Z","timestamp":1783004096423,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.thromres.2024.109144","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:27:02Z","timestamp":1725938822000},"page":"109144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome"],"prefix":"10.1016","volume":"243","author":[{"given":"Michal Mia","family":"Shalamov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichay","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal J.","family":"Simchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Agmon-Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudi","family":"Misgav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Machtinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.109144_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.thromres.2024.109144_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5152\/eurjrheum.2015.0085","article-title":"The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus","volume":"3","author":"Unlu","year":"2016","journal-title":"Eur J Rheumatol."},{"issue":"4","key":"10.1016\/j.thromres.2024.109144_bb0015","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3390\/ijms20040892","article-title":"The impact of autoantibodies on ivf treatment and outcome: a systematic review","volume":"20","author":"Simopoulou","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2024.109144_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13470","article-title":"Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment: a systematic review and meta-analysis","volume":"86","author":"Gao","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.thromres.2024.109144_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103038","article-title":"Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Giambalvo","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.thromres.2024.109144_bb0030","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"Eular recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2024.109144_bb0035","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.thromres.2024.109144_bb0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1472-6483(10)60847-4","article-title":"Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple","volume":"11","author":"Urman","year":"2005","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.thromres.2024.109144_bb0045","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1073\/pnas.88.8.3069","article-title":"Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies","volume":"88","author":"Blank","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2024.109144_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101369","article-title":"Infertility in women with systemic autoimmune diseases","volume":"33","author":"Khizroeva","year":"2019","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2024.109144_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260759","article-title":"Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: a systematic review and meta-analysis","volume":"17","author":"Papadimitriou","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.thromres.2024.109144_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.986893","article-title":"Anticardiolipin and\/or anti-beta2-glycoprotein-i antibodies are associated with adverse ivf outcomes","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2024.109144_bb0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3899\/jrheum.170064","article-title":"Safety and efficacy of in vitro fertilization in women with systemic lupus erythematosus and antiphospholipid syndrome","volume":"44","author":"Genest","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.thromres.2024.109144_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1472-6483(10)61009-7","article-title":"Safety of ivf under anticoagulant therapy in patients at risk for thrombo-embolic events","volume":"12","author":"Yinon","year":"2006","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.thromres.2024.109144_bb0075","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/oxfordjournals.humrep.a137461","article-title":"Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state?","volume":"6","author":"Aune","year":"1991","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.thromres.2024.109144_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9378(81)90744-4","article-title":"Response of blood coagulation parameters to elevated endogenous 17 beta-estradiol levels induced by human menopausal gonadotropins","volume":"140","author":"Kim","year":"1981","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2024.109144_bb0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0163-7827(02)00048-6","article-title":"Antiphospholipid antibodies: discovery, definitions, detection and disease","volume":"42","author":"Mcintyre","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.thromres.2024.109144_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (aps)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109144_bb0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13048-015-0187-6","article-title":"Triggering final follicular maturation--hcg, gnrh-agonist or both, when and to whom?","volume":"8","author":"Orvieto","year":"2015","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.thromres.2024.109144_bb0100","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.fertnstert.2014.02.036","article-title":"Is the modified natural in vitro fertilization cycle justified in patients with \u201cgenuine\u201d poor response to controlled ovarian hyperstimulation?","volume":"101","author":"Kedem","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.thromres.2024.109144_bb0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10815-017-0877-7","article-title":"Outcome of gestational surrogacy according to ivf protocol","volume":"34","author":"Machtinger","year":"2017","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.thromres.2024.109144_bb0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.fertnstert.2010.06.037","article-title":"A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?","volume":"95","author":"Machtinger","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.thromres.2024.109144_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.envint.2017.11.011","article-title":"Urinary concentrations of biomarkers of phthalates and phthalate alternatives and ivf outcomes","volume":"111","author":"Machtinger","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.thromres.2024.109144_bb0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 american college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.thromres.2024.109144_bb0125","series-title":"Delayed Intra-abdominal Bleeding Following Trans-vaginal Ultrasonography Guided Oocyte Retrieval for In Vitro Fertilization in Patients at Risk for Thrombo-embolic Events Under Anticoagulant Therapy","author":"Mashiach","year":"2013"},{"key":"10.1016\/j.thromres.2024.109144_bb0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.thromres.2009.08.001","article-title":"Heparin and maternal fetal interface: why should it work to prevent pregnancy complications?","volume":"124","author":"Hossain","year":"2009","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.109144_bb0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humupd\/dmn031","article-title":"The potential role of heparin in assisted conception","volume":"14","author":"Nelson","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.thromres.2024.109144_bb0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1477-7827-11-98","article-title":"A retrospective study on ivf\/icsi outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment","volume":"11","author":"Zhu","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.thromres.2024.109144_bb0145","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2024.109144_bb0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3899\/jrheum.160462","article-title":"In vitro fertilization in 37 women with systemic lupus erythematosus or antiphospholipid syndrome: a series of 97 procedures","volume":"44","author":"Orquevaux","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.thromres.2024.109144_bb0155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:01:35Z","timestamp":1729076495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824002767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"alternative-id":["S0049384824002767"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109144","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109144"}}